Cargando…

TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis

Rationale: Enhancing non–CFTR (cystic fibrosis transmembrane conductance regulator)-mediated anion secretion is an attractive therapeutic approach for the treatment of cystic fibrosis (CF) and other mucoobstructive diseases. Objectives: To determine the effects of TMEM16A potentiation on epithelial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danahay, Henry L., Lilley, Sarah, Fox, Roy, Charlton, Holly, Sabater, Juan, Button, Brian, McCarthy, Clive, Collingwood, Stephen P., Gosling, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159426/ https://www.ncbi.nlm.nih.gov/pubmed/31898911 http://dx.doi.org/10.1164/rccm.201908-1641OC

Ejemplares similares

TMEM16A: An Alternative Approach to Restoring Airway Anion Secretion in Cystic Fibrosis?
por: Danahay, Henry, et al.
Publicado: (2020)

Niclosamide does not modulate airway epithelial function through blocking of the calcium activated chloride channel, TMEM16A
por: Danahay, Henry, et al.
Publicado: (2023)

Potentiating TMEM16A does not stimulate airway mucus secretion or bronchial and pulmonary arterial smooth muscle contraction
por: Danahay, Henry, et al.
Publicado: (2020)

Reply to Olschewski et al.: TMEM16A Potentiation: Possible Drawbacks
por: Danahay, Henry L., et al.
Publicado: (2020)

TMEM16A in Cystic Fibrosis: Activating or Inhibiting?
por: Kunzelmann, Karl, et al.
Publicado: (2019)

TMEM16A Potentiators: Is There a Need for New Modulators in Cystic Fibrosis?
por: Kim, Michael D., et al.
Publicado: (2020)

TMEM16A/ANO1: Current Strategies and Novel Drug Approaches for Cystic Fibrosis
por: Mitri, Christie, et al.
Publicado: (2021)

Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia
por: Veit, Guido, et al.
Publicado: (2012)

Development of the Olfactory Epithelium and Nasal Glands in TMEM16A(-/-) and TMEM16A(+/+) Mice
por: Maurya, Devendra Kumar, et al.
Publicado: (2015)

Optimising inhaled mannitol for cystic fibrosis in an adult population
por: Flume, Patrick A., et al.
Publicado: (2015)

Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251)
por: Kazani, Shamsah, et al.
Publicado: (2021)

Coexistence of cystic fibrosis and phenylketonuria.
por: Greeves, L. G., et al.
Publicado: (1997)

The role of TMEM16A (ANO1) and TMEM16F (ANO6) in cell migration
por: Jacobsen, K. S., et al.
Publicado: (2013)

Cellular functions of TMEM16/anoctamin
por: Oh, Uhtaek, et al.
Publicado: (2016)

Contrasting effects of phosphatidylinositol 4,5‐bisphosphate on cloned TMEM16A and TMEM16B channels
por: Ta, Chau M, et al.
Publicado: (2017)

Dynamic regulation of airway surface liquid pH by TMEM16A and SLC26A4 in cystic fibrosis nasal epithelia with rare mutations
por: Delpiano, Livia, et al.
Publicado: (2023)

TMEM16F may be a new therapeutic target for Alzheimer’s disease
por: Cui, Zhi-Qiang, et al.
Publicado: (2022)

TMEM16 chloride channels are two-faced
por: Hartzell, H. Criss, et al.
Publicado: (2016)

Lifting the veils on TMEM16E function
por: Boccaccio, Anna, et al.
Publicado: (2019)

TMEM16A Potentiation: Possible Drawbacks
por: Olschewski, Andrea, et al.
Publicado: (2020)

TMEM16A and TMEM16B Modulate Pheromone-Evoked Action Potential Firing in Mouse Vomeronasal Sensory Neurons
por: Hernandez-Clavijo, Andres, et al.
Publicado: (2021)

Contribution of TMEM16F to pyroptotic cell death
por: Ousingsawat, Jiraporn, et al.
Publicado: (2018)

Regulation and Function of TMEM16F in Renal Podocytes
por: Schenk, Laura K., et al.
Publicado: (2018)

TMEM16K is an interorganelle regulator of endosomal sorting
por: Petkovic, Maja, et al.
Publicado: (2020)

Polymodal Control of TMEM16x Channels and Scramblases
por: Agostinelli, Emilio, et al.
Publicado: (2022)

Niclosamide potentiates TMEM16A and induces vasoconstriction
por: Liang, Pengfei, et al.
Publicado: (2023)

The Anion Channel TMEM16a/Ano1 Modulates CFTR Activity, but Does Not Function as an Apical Anion Channel in Colonic Epithelium from Cystic Fibrosis Patients and Healthy Individuals
por: Salari, Azam, et al.
Publicado: (2023)

Identification of a conserved drug binding pocket in TMEM16 proteins
por: Cheng, Yifan, et al.
Publicado: (2022)

TMEM16A alternative splicing coordination in breast cancer
por: Ubby, Ifeoma, et al.
Publicado: (2013)

Single-molecule analysis of phospholipid scrambling by TMEM16F
por: Watanabe, Rikiya, et al.
Publicado: (2018)

Known structures and unknown mechanisms of TMEM16 scramblases and channels
por: Falzone, Maria E., et al.
Publicado: (2018)

Epithelial Chloride Transport by CFTR Requires TMEM16A
por: Benedetto, Roberta, et al.
Publicado: (2017)

TMEM16F/Anoctamin 6 in Ferroptotic Cell Death
por: Ousingsawat, Jiraporn, et al.
Publicado: (2019)

Recent progress in structural studies on TMEM16A channel
por: Shi, Sai, et al.
Publicado: (2020)

Divalent Cation Modulation of Ion Permeation in TMEM16 Proteins
por: Nguyen, Dung M., et al.
Publicado: (2021)

The Prognostic Value and Mechanisms of TMEM16A in Human Cancer
por: Chen, Wenjian, et al.
Publicado: (2021)

Functional expression of TMEM16A in taste bud cells
por: Guarascio, Domenico M., et al.
Publicado: (2021)

Gating and Regulatory Mechanisms of TMEM16 Ion Channels and Scramblases
por: Le, Son C., et al.
Publicado: (2021)

TMEM16 scramblases thin the membrane to enable lipid scrambling
por: Falzone, Maria E., et al.
Publicado: (2022)

Phospholipid scrambling by a TMEM16 homolog of Arabidopsis thaliana
por: Boccaccio, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a7811lf1dui08kh77u8n02h240